These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22609385)

  • 1. Increased risk for persistent intestinal metaplasia in patients with Barrett's esophagus and uncontrolled reflux exposure before radiofrequency ablation.
    Krishnan K; Pandolfino JE; Kahrilas PJ; Keefer L; Boris L; Komanduri S
    Gastroenterology; 2012 Sep; 143(3):576-581. PubMed ID: 22609385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hiatal hernia size and columnar segment length on the success of radiofrequency ablation for Barrett's esophagus: a single-center, phase II clinical trial.
    Korst RJ; Santana-Joseph S; Rutledge JR; Antler A; Bethala V; DeLillo A; Kutner D; Lee BE; Pazwash H; Pittman RH; Rahmin M; Rubinoff M
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1168-73. PubMed ID: 21840549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophageal motility and impedance characteristics in patients with Barrett's esophagus before and after radiofrequency ablation.
    Hemmink GJ; Alvarez Herrero L; Bogte A; Bredenoord AJ; Bergman JJ; Smout AJ; Weusten BL
    Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1024-32. PubMed ID: 23708277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Nissen fundoplication on endoscopic endoluminal radiofrequency ablation of Barrett's esophagus.
    O'Connell K; Velanovich V
    Surg Endosc; 2011 Mar; 25(3):830-4. PubMed ID: 20676687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors that predict a poor response to radiofrequency ablation for Barrett's oesophagus with dysplasia.
    Tsoi EH; Cameron G; Williams R; Desmond P; Taylor A
    ANZ J Surg; 2020 Mar; 90(3):272-276. PubMed ID: 31970858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
    Wani S; Rubenstein JH; Vieth M; Bergman J
    Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Two-stage treatment of Barrett's esophagus].
    Puchkov KV; Khabarova EV; Tishchenko ES
    Khirurgiia (Mosk); 2019; (9):18-24. PubMed ID: 31532162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Durability of radiofrequency ablation in Barrett's esophagus with dysplasia.
    Shaheen NJ; Overholt BF; Sampliner RE; Wolfsen HC; Wang KK; Fleischer DE; Sharma VK; Eisen GM; Fennerty MB; Hunter JG; Bronner MP; Goldblum JR; Bennett AE; Mashimo H; Rothstein RI; Gordon SR; Edmundowicz SA; Madanick RD; Peery AF; Muthusamy VR; Chang KJ; Kimmey MB; Spechler SJ; Siddiqui AA; Souza RF; Infantolino A; Dumot JA; Falk GW; Galanko JA; Jobe BA; Hawes RH; Hoffman BJ; Sharma P; Chak A; Lightdale CJ
    Gastroenterology; 2011 Aug; 141(2):460-8. PubMed ID: 21679712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of subsquamous high-grade dysplasia and adenocarcinoma after successful radiofrequency ablation of Barrett's esophagus.
    Titi M; Overhiser A; Ulusarac O; Falk GW; Chak A; Wang K; Sharma P
    Gastroenterology; 2012 Sep; 143(3):564-566.e1. PubMed ID: 22561053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation for Barrett's esophagus and low-grade dysplasia in combination with an antireflux procedure: a new paradigm.
    dos Santos RS; Bizekis C; Ebright M; DeSimone M; Daly BD; Fernando HC
    J Thorac Cardiovasc Surg; 2010 Mar; 139(3):713-6. PubMed ID: 20074750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia.
    Pouw RE; Wirths K; Eisendrath P; Sondermeijer CM; Ten Kate FJ; Fockens P; Devière J; Neuhaus H; Bergman JJ
    Clin Gastroenterol Hepatol; 2010 Jan; 8(1):23-9. PubMed ID: 19602454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Barrett's metaplasia the source of adenocarcinomas of the cardia?
    Clark GW; Smyrk TC; Burdiles P; Hoeft SF; Peters JH; Kiyabu M; Hinder RA; Bremner CG; DeMeester TR
    Arch Surg; 1994 Jun; 129(6):609-14. PubMed ID: 8204035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors of radiofrequency ablation failure in the treatment of dysplastic Barrett's esophagus.
    Weiss S; Pellat A; Corre F; Abou Ali E; Belle A; Terris B; Leconte M; Dohan A; Chaussade S; Coriat R; Barret M
    Clin Res Hepatol Gastroenterol; 2023 Jan; 47(1):102065. PubMed ID: 36494071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium.
    Gupta M; Iyer PG; Lutzke L; Gorospe EC; Abrams JA; Falk GW; Ginsberg GG; Rustgi AK; Lightdale CJ; Wang TC; Fudman DI; Poneros JM; Wang KK
    Gastroenterology; 2013 Jul; 145(1):79-86.e1. PubMed ID: 23499759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study.
    van Vilsteren FG; Alvarez Herrero L; Pouw RE; Schrijnders D; Sondermeijer CM; Bisschops R; Esteban JM; Meining A; Neuhaus H; Parra-Blanco A; Pech O; Ragunath K; Rembacken B; Schenk BE; Visser M; ten Kate FJ; Meijer SL; Reitsma JB; Weusten BL; Schoon EJ; Bergman JJ
    Endoscopy; 2013 Jul; 45(7):516-25. PubMed ID: 23580412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
    Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
    Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation in Barrett's esophagus with dysplasia.
    Shaheen NJ; Sharma P; Overholt BF; Wolfsen HC; Sampliner RE; Wang KK; Galanko JA; Bronner MP; Goldblum JR; Bennett AE; Jobe BA; Eisen GM; Fennerty MB; Hunter JG; Fleischer DE; Sharma VK; Hawes RH; Hoffman BJ; Rothstein RI; Gordon SR; Mashimo H; Chang KJ; Muthusamy VR; Edmundowicz SA; Spechler SJ; Siddiqui AA; Souza RF; Infantolino A; Falk GW; Kimmey MB; Madanick RD; Chak A; Lightdale CJ
    N Engl J Med; 2009 May; 360(22):2277-88. PubMed ID: 19474425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic and therapeutic management of Barrett's esophagus].
    Müller-Gerbes D; Aymaz S; Dormann A
    Dtsch Med Wochenschr; 2011 Sep; 136(36):1796-800. PubMed ID: 21882137
    [No Abstract]   [Full Text] [Related]  

  • 19. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia.
    Csendes A; Smok G; Quiroz J; Burdiles P; Rojas J; Castro C; Henríquez A
    Am J Gastroenterol; 2002 Mar; 97(3):554-60. PubMed ID: 11922546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.